DIANEAL PD-2 Peritoneal Dialysis with 2.5% w/v Glucose Solution Australia - English - Department of Health (Therapeutic Goods Administration)

dianeal pd-2 peritoneal dialysis with 2.5% w/v glucose solution

baxter healthcare pty ltd - glucose monohydrate, quantity: 25 g/l; sodium chloride, quantity: 5.38 g/l; sodium lactate, quantity: 4.48 g/l; calcium chloride dihydrate, quantity: 257 mg/l; magnesium chloride hexahydrate, quantity: 50.8 mg/l - solution, irrigation - excipient ingredients: hydrochloric acid; sodium hydroxide; water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code),dianeal low calcium peritoneal dialysis solution is indicated for use in chronic renal failure patients being maintained on continuous ambulatory peritoneal dialysis or intermittent peritoneal dialysis and/or automated peritoneal dialysis and can also be used for acute renal failure.

DIANEAL PD-2 Peritoneal Dialysis with 1.5% w/v Glucose Solution Australia - English - Department of Health (Therapeutic Goods Administration)

dianeal pd-2 peritoneal dialysis with 1.5% w/v glucose solution

baxter healthcare pty ltd - glucose monohydrate, quantity: 15 g/l; sodium chloride, quantity: 5.38 g/l; sodium lactate, quantity: 4.48 g/l; calcium chloride dihydrate, quantity: 257 mg/l; magnesium chloride hexahydrate, quantity: 50.8 mg/l - solution, irrigation - excipient ingredients: hydrochloric acid; sodium hydroxide; water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code),dianeal low calcium peritoneal dialysis solution is indicated for use in chronic renal failure patients being maintained on continuous ambulatory peritoneal dialysis or intermittent peritoneal dialysis and/or automated peritoneal dialysis and can also be used for acute renal failure.

DIANEAL PD-2 Peritoneal Dialysis with 0.55% w/v Glucose Solution Australia - English - Department of Health (Therapeutic Goods Administration)

dianeal pd-2 peritoneal dialysis with 0.55% w/v glucose solution

baxter healthcare pty ltd - glucose monohydrate, quantity: 5.5 g/l; sodium chloride, quantity: 5.38 g/l; sodium lactate, quantity: 4.48 g/l; calcium chloride dihydrate, quantity: 257 mg/l; magnesium chloride hexahydrate, quantity: 50.8 mg/l - solution, irrigation - excipient ingredients: hydrochloric acid; sodium hydroxide; water for injections - dianeal low calcium peritoneal dialysis solution is indicated for use in chronic renal failure patients being maintained on continuous ambulatory peritoneal dialysis or intermittent peritoneal dialysis and/or automated peritoneal dialysis and can also be used for acute renal failure.

DIANEAL Low Calcium 2.5% w/v Glucose Australia - English - Department of Health (Therapeutic Goods Administration)

dianeal low calcium 2.5% w/v glucose

baxter healthcare pty ltd - glucose, quantity: 25 g/l; sodium chloride, quantity: 5.38 g/l; sodium lactate, quantity: 4.48 g/l; calcium chloride dihydrate, quantity: 183 mg/l; magnesium chloride hexahydrate, quantity: 50.8 mg/l - solution, irrigation - excipient ingredients: hydrochloric acid; water for injections - dianeal low calcium peritoneal dialysis solution is indicated for use in chronic renal failure patients being maintained on continuous ambulatory peritoneal dialysis or intermittent peritoneal dialysis, and/or automated peritoneal dialysis. can also be used for acute renal failure.

DIANEAL Low Calcium 1.5% w/v Glucose Australia - English - Department of Health (Therapeutic Goods Administration)

dianeal low calcium 1.5% w/v glucose

baxter healthcare pty ltd - glucose, quantity: 15 g/l; sodium chloride, quantity: 5.38 g/l; sodium lactate, quantity: 4.48 g/l; calcium chloride dihydrate, quantity: 183 mg/l; magnesium chloride hexahydrate, quantity: 50.8 mg/l - solution, irrigation - excipient ingredients: hydrochloric acid; water for injections - dianeal low calcium peritoneal dialysis solution is indicated for use in chronic renal failure patients being maintained on continuous ambulatory peritoneal dialysis or intermittent peritoneal dialysis, and/or automated peritoneal dialysis. can also be used for acute renal failure.

General-purpose surgical drape, single-use, non-sterile Australia - English - Department of Health (Therapeutic Goods Administration)

general-purpose surgical drape, single-use, non-sterile

defries industries pty ltd - 47782 - general-purpose surgical drape, single-use, non-sterile - to isolate a site of surgical incision or a surgical field from contamination in various clinical settings. it may also be used to protect a patient from heat/flame during a surgical procedure.

EPIGAEA REPENS pellet United States - English - NLM (National Library of Medicine)

epigaea repens pellet

washington homeopathic products - epigaea - to relieve the symptoms of urinary problems. indications: epigaea   urinary problems if symptoms persist/worsen or if pregnant/nursing, stop use and consult your practitioner.

CYCLOBENZAPRINE HYDROCHLORIDE tablet, film coated United States - English - NLM (National Library of Medicine)

cyclobenzaprine hydrochloride tablet, film coated

st. mary's medical park pharmacy - cyclobenzaprine hydrochloride (unii: 0ve05jys2p) (cyclobenzaprine - unii:69o5wqq5ti) - cyclobenzaprine hydrochloride tablets, usp are indicated as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions. improvement is manifested by relief of muscle spasm and its associated signs and symptoms, namely, pain, tenderness, limitation of motion, and restriction in activities of daily living. cyclobenzaprine hydrochloride tablets should be used only for short periods (up to 2 or 3 weeks) because adequate evidence of effectiveness for more prolonged use is not available and because muscle spasm associated with acute, painful musculoskeletal conditions is generally of short duration and specific therapy for longer periods is seldom warranted. cyclobenzaprine hydrochloride tablets have not been found effective in the treatment of spasticity associated with cerebral or spinal cord disease, or in children with cerebral palsy. hypersensitivity to any component of this product. concomitant use of monoamine oxidase (mao) inhibitors or withi

LIPITOR 10 MG FILM-COATED TABLETS Ireland - English - HPRA (Health Products Regulatory Authority)

lipitor 10 mg film-coated tablets

imed healthcare ltd. - atorvastatin-calcium - film coated tablet - 10 base milligrams

LIPITOR 20 MG FILM-COATED TABLETS Ireland - English - HPRA (Health Products Regulatory Authority)

lipitor 20 mg film-coated tablets

imed healthcare ltd. - atorvastatin-calcium - film coated tablet - 20 base milligrams